# Innate Pharma SA: Form 6-K, filed Mar 10, 2020

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2020-03-10
- Accepted by EDGAR: Mar 10, 2020, 06:30 ET
- Period: 2020-03-10
- Accession: 0001171843-20-001582
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000117184320001582/f6k_030920.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000117184320001582/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000117184320001582/f6k_030920.htm

Filed Mar 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001171843-20-001582. Last ingested by Listed: Nov 12, 2026, 17:11 ET. No prices; not investment advice.
